Showing results (271-280 of 598) with videos related to
Sort By:
Pageof 60
Expert Review of Neurotherapeutics|July 20, 2021
Exploring the role of botulinum toxin in critical careMuhammad Ubaid Hafeez, Michael Moore, Komal Hafeez, et al.Journal of Neurology|May 14, 2022
Dystonic motor and phonic tics in Tourette syndromeJosé Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Joseph JankovicF1000Research|July 29, 2017
Progress toward an integrated understanding of Parkinson's diseaseMaxime W C Rousseaux, Joshua M Shulman, Joseph JankovicImmunological Investigations|September 12, 2017
The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin MoleculeMinako Oshima, Philip Deitiker, Joseph Jankovic, et al.Archives of Neurology|May 16, 2007
Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson diseaseJoseph Jankovic, Ray L Watts, Wayne Martin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2006
Subthalamic deep brain stimulation in patients with a previous pallidotomyWilliam G Ondo, Yavuz Silay, Mike Almaguer, et al.Journal of Neurology|December 17, 2025
Functional cervical dystonia: diagnostic accuracy of distinct clinical featuresJosé Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Joseph JankovicJournal of Neural Transmission (Vienna, Austria : 1996)|April 28, 2023
Contrasting features between Tourette syndrome and secondary tic disordersJosé Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Joseph JankovicJournal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|September 13, 2002
H-reflex recovery curves differentiate essential tremor, Parkinson's disease, and the combination of essential tremor and Parkinson's diseaseMohamed Sabbahi, Bruce Etnyre, Ibrahim Al-Jawayed, et al.Parkinsonism & Related Disorders|February 14, 2012
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension studyLawrence W Elmer, Erwin Surmann, Babak Boroojerdi, et al.Pageof 60